Diversity in Clinical Trial Participants: Canada Holds Promise
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
With the emergence of basket trials in the early-phase oncology setting, clinical research teams are faced with challenges of enrollment…
Pediatric Hematology Oncology is a relatively recent area of study. Only in the past 50 years have substantial advances taken…
This time last year none of us imagined we were about to go through a year like no other, and…
Study start-up is one the most time-intensive areas within clinical drug development, accounting for two thirds or more of total…
The COVID-19 world-wide pandemic has forced the clinical trial industry to make rapid changes in order to continue protecting participant…
People often adhere to a myth and perpetuate it in answer to a difficult question, ending all further inquiry into…
Pursuit of a path from discovery to drug approval as quickly as possible is a clear objective for most biotech…
Clinical trials, and in particular oncology studies, can be very complex and often involve multiple parties: Sponsor, CRO (sometimes several…
Whether in Canada or any other country it is no secret that executing Clinical Trial Agreements (CTAs) is often the…